
A fond farewell from Joe Kirwin as he steps down as Chief Executive
I am writing to let you know that I will be moving on from my role as Chief Executive at Pancreatic Cancer Action at the end of March 2025.
I am writing to let you know that I will be moving on from my role as Chief Executive at Pancreatic Cancer Action at the end of March 2025.
Hi, I’m Sharon Jones, and I’m a five-year survivor of pancreatic cancer. Five years ago, if someone had told me I’d be here writing this, I wouldn’t have believed them. When I was diagnosed, I thought it was a death…
Pancreatic cancer is the deadliest of all the common cancers. It has seen little to no improvement in its survival rates for close to 50 years. At Pancreatic Cancer Action, we focus on campaigning to improve earlier diagnosis and to…
In 2016, David McRae, Managing Director of Just Employment Law, our charity partner, experienced unimaginable tragedy. His mother was diagnosed with terminal pancreatic cancer in December 2015, and just six months later, she passed away on the day of David’s…
Since 2023, there has been a global shortage of Pancreatic Enzyme Replacement Therapy (PERT) and is estimated to continue until at least 2026. This shortage is currently affecting more than 60,000 people across the UK.
Jenny Bazely Runs Leicester Half Marathon for Pancreatic Cancer Action After Personal Connection to Diagnosis
The Getting It Right First Time (GIRFT) programme is a national NHS England programme designed to improve the treatment and care of patients through in-depth review of services, benchmarking, and presenting a data-driven evidence base to support change.
On January 15th, representatives from Pancreatic Cancer Action took part in PANcreatic CAncer Initial Detection (PANCAID) 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿 𝗗𝗶𝗮𝗹𝗼𝗴𝘂𝗲 𝗘𝘃𝗲𝗻𝘁 at the European Parliament.
A Survivor's Journey - My Dad's Battle with Pancreatic Cancer.
Pancreatic Cancer Awareness Month 2024 has come to a close and we are so proud of what we have accomplished together.
The Scottish Cancer Conference is an annual event which unites an array of individuals and organisations who are involved with or affected by cancer.